-- 
SWISS DAYBOOK: UBS Equities Heads Resign, Novartis, Swiss Re

-- B y   C o r i n n e   G r e t l e r   a n d   C a r o l y n   B a n d e l
-- 
2011-10-06T05:46:25Z

-- http://www.bloomberg.com/news/2011-10-06/swiss-daybook-ubs-equities-heads-resign-novartis-swiss-re.html
UBS AG (UBSN)  said Francois Gouws and
Yassine Bouhara resigned as co-heads of Global Equities
following the recent unauthorized trading incident.  Mike Stewart will become sole global head of Equities, the
bank said in an e-mailed statement.  EQUITIES:
*Novartis will lower the price of its Lucentis drug by 30
percent, AWP reported
*Zurich Financial Services said it closed the acquisition of 51
percent participation in the life insurance, pension and general
insurance operations of Banco Santander SA in Brazil and
Argentina
*Swiss Re said it “comfortably exceeds” a capital buffer of
between $3 billion and $5 billion required for a Standard &
Poor’s AA capital rating
*Sika AG said it’s agreed to buy Comercial de Preresa
* Galenica AG (GALN)  said its joint venture with Fresenius Medical Care
AG & Co, Vifor Fresenius Medical Care Renal Pharma Ltd., got
Swiss and European antitrust approval and will proceed with the
targeted expansion of its operation in Europe and other
countries after the formal close in November
*Basilea Pharmaceutica AG said shareholder HBM BioVentures has
requested an extraordinary shareholders meeting to elect
additional members to the board of directors
*Nobel Biocare and Straumann were cut to “sell” at Citi
*Kuehne & Nagel said it opened a new distribution center in
Cartagena  WHAT TO WATCH:
*Switzerland’s foreign currency reserves at 9 a.m.
*September consumer price index at 9:15 a.m.  MARKETS:
*The SMI climbed 1.1 percent to 5,504.99
*The SPI rose 1.2 percent to 4973.87
*The Stoxx Europe 600 Index increased 3.1 percent to 224.15
*The MSCI Asia-Pacific Index rose 2.6 percent at 7:39 a.m.
Zurich time
*Euro-franc traded at 1.23069 at 7:43 a.m. Zurich time  To contact the reporters on this story:
Corinne Gretler in Zurich at 
 cgretler1@bloomberg.net ;
Carolyn Bandel in Zurich at 
 cbandel@bloomberg.net   To contact the editor responsible for this story:
Andrew Rummer at 
 arummer@bloomberg.net  